Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -24.41
- Piotroski Score 4.00
- Grade Neutral
- Symbol (IMPL)
- Company Impel Pharmaceuticals Inc.
- Price $0.04
- Changes Percentage (-27.27%)
- Change -$0.02
- Day Low $0.02
- Day High $0.05
- Year High $4.20
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. Impel Pharmaceuticals Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.12
- Trailing P/E Ratio -0.012820512820513
- Forward P/E Ratio -0.012820512820513
- P/E Growth -0.012820512820513
- Net Income $-129,440,000
Income Statement
Quarterly
Annual
Latest News of IMPL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Massachusetts governor implements new gun law weeks ahead of schedule
Gun rights activist Maj Toure educates urban communities on Second Amendment rights. Massachusetts implements new gun laws to regulate "ghost guns," requiring safety training for gun licenses. Gun rig...
By Fox News | 1 day ago -
Mauricio Pochettino has big plans for USMNT - but will take his time to implement them
Mauricio Pochettino's first U.S. men's national team roster resembles the one from September, with injuries affecting regular players. Pochettino aims to build a strong foundation, focusing on simplic...
By The New York Times | 2 days ago -
CIA simplifies process for potential informants to share information
The CIA is simplifying the process for potential informants in Iran, China, and North Korea to share intelligence by posting online instructions in Korean, Mandarin, and Farsi. These steps ensure safe...
By Newsweek | 2 days ago
